Latest News about GILD
Recent news which mentions GILD
3 Pharma Stocks With Dividends Above 4% to Buy Now
December 01, 2020
From Motley Fool
9 Health Care Stocks With Unusual Options Alerts In Today's Session
November 30, 2020
From Benzinga
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
November 28, 2020
From Motley Fool
Gilead's New CEO Is Going All-In on Acquisitions
November 28, 2020
From Motley Fool
Is This Coronavirus Treatment Setting Investors Up for Failure?
November 27, 2020
From Motley Fool
This Biotech Is Up 1,500% This Year. Can It Make You Rich in 2021?
November 26, 2020
From Motley Fool
3 High-Yield Stocks at Rock-Bottom Prices
November 25, 2020
From Motley Fool
Better Buy: Gilead Sciences vs. Pfizer
November 23, 2020
From Motley Fool
Could Sorrento Therapeutics Be a Millionaire-Maker Stock?
November 22, 2020
From Motley Fool
This Company's New Approach Could Slash Gilead's Profit From HIV Drugs
November 22, 2020
From Motley Fool
Is There Room for Latecomers to the COVID-19 Party?
November 21, 2020
From Motley Fool
WHO Recommends Against Using Gilead's Remdesivir for COVID-19
November 20, 2020
Tickers
GILD
From Motley Fool
Pharma Sector Did Its Job With COVID-19 Vaccine: Barclays Analyst
November 20, 2020
From Benzinga
Coronavirus update: U.S. moves closer to 200,000 cases a day; Birx and Fauci urge Americans to follow safety measures over Thanksgiving
November 20, 2020
From MarketWatch
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
Stock-index futures mixed as COVID restrictions threaten recovery
November 20, 2020
From MarketWatch
Is Sorrento Therapeutics Stock a Buy?
November 20, 2020
From Motley Fool
A Peek Into The Markets: US Stock Futures Slightly Lower Ahead Of Earnings, Fed Speakers
November 20, 2020
From Benzinga
European stocks inch up, while U.S. futures fall on virus headlines and spending spat between Fed and Treasury
November 20, 2020
Tickers
GILD
From MarketWatch
From Benzinga
From Benzinga
WHO advisers recommend against Gilead’s remdesivir for treating COVID-19
November 19, 2020
Tickers
GILD
Tags
GILD
From MarketWatch
Sorrento CEO Henry Ji on How the Company Got Its Start
November 19, 2020
From Motley Fool
Is Moderna Still a Compelling Growth Play?
November 18, 2020
From Motley Fool
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
From Benzinga
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.